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Abstract
Background: Brains of patients with schizophrenia show both neurodevelopmental and functional deficits that suggest
aberrant glutamate neurotransmission. Evidence from both genetic and pharmacological studies suggests that
glutamatergic dysfunction, particularly with involvement of NMDARs, plays a critical role in the pathophysiology of
schizophrenia. However, how prenatal disturbance of NMDARs leads to schizophrenia-associated developmental defects is
largely unknown.
Methodology/Principal Findings: Glutamate transporter GLAST/GLT1 double-knockout (DKO) mice carrying the NMDA
receptor 1 subunit (NR1)-null mutation were generated. Bouin-fixed and paraffin-embedded embryonic day 16.5 coronal
brain sections were stained with hematoxylin, anti-microtubule-associated protein 2 (MAP2), and anti-L1 antibodies to
visualize cortical, hippocampal, and olfactory bulb laminar structure, subplate neurons, and axonal projections. NR1 deletion
in DKO mice almost completely rescued multiple brain defects including cortical, hippocampal, and olfactory bulb
disorganization and defective corticothalamic and thalamocortical axonal projections.
Conclusions/Significance: Excess glutamatergic signaling in the prenatal stage compromises early brain development via
overstimulation of NMDARs.
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Introduction
While multiple models have been put forth regarding the
pathophysiology of schizophrenia, the vast majority of evidence
suggests that schizophrenia stems from neurodevelopmental
deficits, resulting in disturbance of glutamatergic neurotransmis-
sion and especially NMDA receptor-mediated signaling many
years later [1,2]. NMDAR dysfunction models are based upon the
observation that psychotomimetic agents such as ketamine and
phencyclidine (PCP) induce symptoms of schizophrenia in healthy
subjects and provoke relapse in schizophrenics by blocking
neurotransmission at NMDA receptors [3–6]. In rodents,
NMDAR antagonists induce schizophrenia-related behavioral
abnormalities [6–8]. While these psychotomimetic effects of
NMDAR antagonists have fostered the notion of a hypoglutama-
tergic state in schizophrenia, recent data suggest that these effects
are linked to a loss of NMDAR-mediated GABAergic inhibition,
leading to excessive glutamate release and neuronal hyperexcit-
ability in the prefrontal cortex (PFC) [2]. In support of this model
is the recent demonstration of the antipsychotic efficacy of group II
metabotropic glutamate 2/3 (mGlu2/3) agonists, which decrease
glutamate release and normalize NMDAR antagonist-induced
increases in PFC glutamate [9]. These developments suggest that
elevation in the cellular balance of excitation and inhibition within
the PFC may be involved in the pathophysiology of schizophrenia
[10].
According to the neurodevelopmental model, the etiology of
schizophrenia may involve pathologic processes caused by both
genetic and environmental factors that begin before the brain
approaches its adult anatomical state in adolescence. Multiple lines
of evidence from brain pathology, genetics, environmental factors,
and gene-environment interactions support this neurodevelop-
mental model [1]. Numerous reports document the presence of
various neuropathological findings in schizophrenia patients,
including ventricular enlargement, reduced white and gray matter
diffusion anisotropy, and abnormal laminar organization [1,11–
13]. At the perinatal stage, a major risk for schizophrenia is birth
complications, especially perinatal hypoxia [1]. Since hypoxia
impairs energy-dependent glutamate transport, allowing extracel-
lular glutamate to reach excitotoxic levels [14], it is possible that
increased NMDAR activity caused by excessive glutamate plays
a role in the neurodevelopmental deficits of schizophrenia.
We recently generated mutant mice in which glutamate
receptors are overstimulated by knocking out glutamate trans-
porters GLAST and GLT1, which are essential for maintaining
low extracellular glutamate levels [15]. GLAST/GLT1 double-
knockout (DKO) mice demonstrate multiple brain defects that
are similar to schizophrenia-associated developmental defects,
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36853including enlarged lateral ventricles; disorganization of neo-
cortex, hippocampus, and olfactory bulb due to impaired
neuronal migration; and defective corticothalamic and thalamo-
cortical axonal projections [15]. All glutamate receptor subunit
classes, including NMDA, AMPA, kainite, and metabotropic
receptors, are widely expressed throughout the embryonic brain
[16–19]. To confirm the involvement of excess NMDAR
signaling in these developmental defects, we generated DKO
mice carrying the NMDA receptor 1 subunit (NR1)-null
mutation (triple knockout, TKO) [20]. NR1 deletion in DKO
mice almost completely rescued multiple brain defects including
cortical, hippocampal, and olfactory bulb disorganization and
defective corticothalamic and thalamocortical axonal projections.
Results
NR1 deletion in DKO mice (Fig. 1) almost completely rescued
brain defects in the cerebral cortex (Fig. 2), hippocampus (Fig. 3),
and olfactory bulb (Fig. 4) at E16.5. In E16.5 WT mice, cerebral
cortex is laminated, with the following layers: marginal zone,
cortical plate (CP), subplate, intermediate zone (IZ), and
ventricular zone. In the DKO cerebral cortex, the CP border on
the IZ was obscured. In contrast, this abnormal laminar structure
was completely restored in TKO cerebral cortex (Fig. 2).
Densitometry scans demonstrated apparent border between high
optical density (OD) bins in pial side and adjacent low OD bins,
corresponding to CP and IZ respectively, in WT and TKO
cerebral cortex. In contrast, no apparent border was observed in
DKO cerebral cortex. There was a significant difference in the
average OD of segment 5 (star), corresponding to the CP border
on the IZ, between WT and DKO or TKO and DKO (P,0.01),
but not between WT and TKO.
In the DKO hippocampus, the pyramidal cell layer (PCL) was
less densely packed. In contrast, abnormal PCL structure was
restored in TKO hippocampus (Fig. 3). Densitometry scans
demonstrated apparent OD peaks corresponding to PCL in WT
and TKO hippocampus. In contrast, no OD peak was observed in
DKO hippocampus. There was a significant difference in the
average OD of segment 5 (star), corresponding to the PCL,
between WT and DKO (P,0.01) or TKO and DKO (P,0.05),
but not between WT and TKO.
In the DKO olfactory bulb, the mitral cell layer (MCL) was
absent. In contrast, MCL was restored in TKO olfactory bulb
(Fig. 4). The quantification demonstrated apparent OD peaks
corresponding to MCL in WT and TKO olfactory bulbs. In
contrast, no OD peak was observed in DKO olfactory bulb. There
was a significant difference in the average OD of segment 7 (star),
corresponding to the MCL, between WT and DKO (P,0.01) or
Figure 1. NMDA receptor 1 subunit (NR1) is deleted in the GLAST/GLT1 knock-out (DKO) mice. (A) The mouse GLAST gene is located on
chromosome 15, whereas the mouse GLT1 and NR1 genes are both on chromosome 2, with an allelic distance of 37 cM. The idiogram is obtained
from David Adler’s Idiogram Album (http://www.pathology.washington.edu/research/cytopages/idiograms/mouse/). (B) Mice were genotyped by
genomic polymerase chain reaction (PCR) analysis. WT, wild type; DKO, GLAST/GLT1 double knockout; TKO, GLAST/GLT1/NR1 triple knockout; KOA,
knockout allele; WTA, wild-type allele. (C) Reverse transcription-PCR (RT-PCR) analysis confirmed the absence of GLAST, GLT1, and NR1 in TKO brains.
GAPDH fragment was used as loading control. –RT indicates gene fragment amplification without reverse transcriptase as a negative control.
doi:10.1371/journal.pone.0036853.g001
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results suggest brain defects in the cerebral cortex, hippocampus,
and olfactory bulb in DKO mice were almost completely rescued
by NR1 deletion. Since disturbed laminar and layer organization
in DKO mutants resulted from abnormal radial neuronal
migration [15], these results suggested that excess NMDAR
activity impaired radial migration.
Furthermore, NR1 inactivation rescued subplate neurons,
which are vulnerable to early hypoxic-ischemic brain injury and
important for the development of thalamus–neocortex connections
(Fig. 5A). Consistent with subplate neuron rescue, severe
disruptions to L1-positive corticothalamic and thalamocortical
axonal projections were almost completely restored (Fig. 5B).
Recent report suggested that NR1 deletion from GABAergic
neurons contributes cortical hyperexcitability and schizophrenia-
associated behaviors [2]. We examined the development of
GABAergic neurons using anti-GABA and anti-GAD67 anti-
bodies. In DKO mice, the expression levels of GAD67 and GABA
were increased, whereas their expression pattern was normal. In
TKO mice, the elevated GAD67 and GABA expression returned
to normal (Fig. 6). These results suggest that overstimulation of
NMDAR can accelerate the maturation of GABAergic neurons.
Taken together, these results suggest that excess glutamatergic
signaling via NMDARs, not AMPA, kainite, or metabotropic
glutamate receptors, compromises early brain developmental
processes.
Discussion
Although NMDAR hypofunction does not impair embryonic
brain development, its excessive function appears to be
Figure 2. Rescue of disturbed laminar organization of cerebral cortex of DKO by deletion of NR1. (Upper panels) NR1 deletion in DKO
rescued disturbed laminar organization of cerebral cortex. Paraffin-embedded E16.5 coronal brain sections were stained with hematoxylin. Scale bar:
200 mm. (Lower panel) Quantitative analysis of laminar organization of cerebral cortex. To quantify the optical density (OD), densitometry scans of
the boxed regions (shown in upper panels, 100 mm width) were performed. The pia-ventricular extent was normalized by dividing it into 100 bins (x-
axis). Average values of normalized OD in each bin (y-axis) were plotted along the pia-ventricular axis. Three independent embryos for each genotype
were used (black: WT, red: DKO, blue: TKO). Data are mean 6 s.e.m. Statistical significance was calculated every 10 bins (segment, x-axis scale marks).
**P,0.01 compared to DKO (black: WT, blue: TKO) in segment 5 (star) by one-way ANOVA followed by Scheffe ´’s post-hoc analysis. CP: cortical plate,
IZ: intermediate zone.
doi:10.1371/journal.pone.0036853.g002
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activation recapitulated schizophrenia-related pathologies in
embryonic mouse brain, including enlarged lateral ventricles,
disorganization of neocortex and hippocampus, and defective
corticothalamic and thalamocortical axonal projections. These
data raise the possibility that molecular abnormalities leading to
hyper-NMDAR function in the embryonic brain could be risk
factors for schizophrenia.
In contrast to glutamatergic neural circuit, excessive NMDAR
activation in embryonic brain does not impair GABAergic neural
circuit development. Instead, overstimulation of NMDAR can
accelerate the maturation of GABAergic neurons. These results
agree with the previous finding that chronic NMDA exposure
accelerate development of GABAergic inhibition in the superior
colliculus [21] and may be consistent with the previous result that
genetic NR1 deletion in GABAergic neurons impairs the
maturation of GABAergic neurons [2]. Since GABA is excitatory
in the embryonic brain [22], the functional consequence of GABA
and GAD67 elevations warrants future research.
Fetal hypoxia is a common risk factor for a range of
neurological and psychiatric disorders including schizophrenia,
autism, and epilepsy [23]. These disorders are associated with
disruption of the laminar organization of the cerebral cortex. It is
suggested that at least 50% of known susceptibility genes for
schizophrenia are more likely than randomly-selected genes to be
regulated by hypoxia [24]. Furthermore, GLT1, an ‘‘ischemia–
hypoxia response gene,’’ is downregulated in the amygdala of
patients with schizophrenia [25]. Since energy failure, as in
hypoxic episodes, impairs energy-dependent glutamate transport
allowing extracellular glutamate to reach excitotoxic levels [14],
Figure 3. Rescue of disturbed pyramidal cell layer organization of hippocampus of DKO by deletion of NR1. (Upper panels) NR1
deletion in DKO rescued disturbed pyramidal cell lyaer organization of hippocampus. Paraffin-embedded E16.5 coronal brain sections were stained
with hematoxylin. Scale bar: 200 mm. (Lower panel) Quantitative analysis of laminar organization of hippocampus. To quantify OD, densitometry
scans of the boxed regions (shown in upper panels, 100 mm width) were performed. The pia-ventricular extent was normalized by dividing it into 100
bins (x-axis). Average values of normalized OD in each bin (y-axis) were plotted along the pia-ventricular axis. Three independent embryos for each
genotype were used (black: WT, red: DKO, blue: TKO). Data are mean 6 s.e.m. Statistical significance was calculated every 10 bins (segment, x-axis
scale marks). **P,0.01 between WT and DKO and *P,0.01 between TKO and DKO in segment 5 (star) by one-way ANOVA followed by Scheffe ´’s post-
hoc analysis. PCL: pyramidal cell layer.
doi:10.1371/journal.pone.0036853.g003
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mental abnormalities via overstimulation of NMDARs. Recently,
chromosomal microdeletions of GLAST and GLT1 were linked to
schizophrenia [26–28] and Wilms tumor, Aniridia, Genitourinary
malformations and mental Retardation (WAGR) syndrome [29],
respectively, and GLT1 (on 11p12-p13) was located near an
autism risk locus [30]. DKO mice reproduce important patho-
physiological events documented in human mental disorders,
including impaired neuronal migration and cortical connections.
Thus, DKO mice provide a useful tool for elucidating how
embryonic disturbance of glutamate may be associated with the
neurodevelopmental defects underlying neuropsychiatric develop-
mental disorders.
Complex behavioral phenotypes such as those observed in
schizophrenia and autism are hypothesized to arise from elevation
in the ratio of cortical cellular excitation to inhibition (cellular E/I
balance) [10]. This hypothesis could unify diverse genetic and
environmental factors under a common pathophysiological
principle. Our results indicate that elevated cellular E/I balance
in the embryonic brain impairs brain development via hyperfunc-
tion of NMDARs. Elevation of cellular E/I balance in the adult
brain by treatment with NMDAR antagonists such as ketamine
and PCP mimics the symptoms of schizophrenia via the
hypofunction of NMDARs in GABAergic interneurons [2,31–
33]. Thus, the elevated cellular E/I balance hypothesis could
account for disturbance of neurodevelopment and neurotransmis-
sion in neuropsychiatric developmental disorders.
Our results suggest that offset of excessive NMDAR activity
may prevent abnormal brain development due to excess
glutamatergic signaling, thereby avoiding later mental disorders.
Figure 4. Rescue of disturbed mitral cell layer organization of olfactory bulb of DKO by deletion of NR1. (Upper panels) NR1 deletion
in DKO rescued disturbed mitral cell lyaer organization of olfactory bulb. Paraffin-embedded E16.5 coronal brain sections were stained with
hematoxylin. Scale bar: 200 mm. (Lower panel) Quantitative analysis of laminar organization of olfactory bulb. To quantify OD, densitometry scans of
the boxed regions (shown in upper panels, 100 mm width) were performed. The pia-ventricular extent was normalized by dividing it into 100 bins (x-
axis). Average values of normalized OD in each bin (y-axis) were plotted along the pia-ventricular axis. Three independent embryos for each genotype
were used (black: WT, red: DKO, blue: TKO). Data are mean 6 s.e.m. Statistical significance was calculated every 10 bins (segment, x-axis scale marks).
**P,0.01 between WT and DKO and *P,0.05 between TKO and DKO in segment 5 (star) by one-way ANOVA followed by Scheffe ´’s post-hoc analysis.
MCL: mitral cell layer.
doi:10.1371/journal.pone.0036853.g004
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Animals
GLAST[34],GLT1[35],andtheNMDAR-1subunit(NR1)[20]
mutant mice were described previously. Triple-knockout mice were
generated by crossing GLT1(+/2) mice with NR1(+/2) mice to
obtain GLT1/NR1 double-heterozygous mice [GLT1(+/2)/
NR1(+/2)], and then breeding GLAST(2/2) male mice with
GLT1(+/2)/NR1(+/2) female mice to obtain GLAST/GLT1/
NR1 triple-heterozygous mice [GLAST(+/2)/GLT1(+/2)/
NR1(+/2)]. Finally, GLAST(+/2)/GLT1(+/2)/NR1(+/2) mice
were interbred to obtain GLAST/GLT1/NR1 triple-knockout
mice. All mice were of C57BL/6J background. Mice were
genotyped with tail genomic DNA by described protocols for
GLAST [34] and GLT1 [35]. For NR1, a set of NR1 primers for
wild-type allele [36] and a set of primers for mutant allele (NR1, 59-
AGGAGTGGAACGGAATGATG-39; Neo, 59-CAGAAAGC-
GAAGGAGCAAAG-39) were used. The day of vaginal plug
detection was designated E0.5. All research and animal care
procedures were approved by the Tokyo Medical and Dental
University Animal Care and Use Committee (0120292C).
Histology and Immunohistochemistry
As previously described [15], at E16.5, pregnant mice were
killed by cervical dislocation, and embryos were fixed with
Bouin’s fixative. Three independent embryos for each genotype
were used. Paraffin-embedded sections (4 mm) were prepared.
Hematoxylin staining was performed following standard proto-
cols. Images were acquired under the constant exposure
condition using a BIOREVO BZ-9000 microscope (Keyence,
Osaka, Japan). For immunohistochemistry, deparaffinized sec-
tions were placed in an antigen retrieval solution (Immunosaver,
Nisshin EM, Tokyo, Japan) for 45 min at 95uC and incubated
with primary antibodies for 12 h at 4uC. The following
antibodies were used: monoclonal anti-microtubule-associated
protein 2 (MAP2) (SMI, Lutherville, MD), polyclonal anti-L1 (a
gift from H. Kamiguchi, RIKEN Brain Science Institute),
monoclonal anti- glutamic acid decarboxylase 67 (GAD67)
Figure 5. Rescue of subplate neurons and cortical connections of DKO by deletion of NR1. NR1 deletion in DKO rescued (A) subplate
neurons (arrowheads); and (B) impaired cortical connections. Paraffin-embedded E16.5 coronal brain sections were stained with anti-microtubule-
associated protein 2 (MAP2) (A), and anti-L1 antibodies (B). (A, B) Upper-row boxed regions are enlarged in lower row. Scale bar: upper row, 500 mm;
lower row, 200 mm.
doi:10.1371/journal.pone.0036853.g005
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tyric acid (GABA) (Sigma, St. Louis, MO). MAP2 was visualized
by Alexa Fluor 488-conjugated goat anti-mouse IgG (Molecular
Probes, Eugene, OR). L1, GAD67 and GABA were visualized by
Envision-Plus Rabbit HRP System (DakoCytomation, Carpin-
teria, CA) and TSA plus Cyanine 3 system (Perkin-Elmer Life
Sciences, Boston, MA) according to manufacturer’s instructions.
Images were acquired on an LSM 510 META laser-scanning
confocal microscope (Carl Zeiss, Thornwood, NY).
Normalized Optical Density Measurement of
Hematoxylin Stained Sections
To quantify the optical density (OD) of the hematoxylin stained
sections, boxed regions (100 mm width) shown in Figs. 2, 3, 4 were
selected, converted to 8-bit encoded grayscale and inverted to
white on black, and then pixel intensity profiles along pia-ventricle
axis in each region were measured using ImageJ software (3–5
sections for each embryo). In order to adjust intersectional
variability of the absolute level of intensity, minimal OD value
within each region was subtracted as background from individual
OD values, then, individual OD values were normalized to the
maximal OD value on each region. In order to adjust variations of
section size, the pia-ventricular extent of the cerebral cortex,
hippocampus and olfactory bulb were normalized by dividing
those into 100 bins equally spaced along the pia-ventricular axis.
Average values of normalized OD in each bin were plotted along
the pia-ventricular axis. Three independent embryos for each
genotype were used. Data are mean 6 s.e.m. Statistical
Figure 6. Restoration of increased levels of GAD67 and GABA in DKO by deletion of NR1. DKO showed increased levels of GAD67 and
GABA. NR1 deletion in DKO reversed the increased (A) GAD67 and (B) GABA expression. Paraffin-embedded E16.5 coronal brain sections were stained
with anti-glutamic acid decarboxylase 67 (GAD67) (A), and anti-gamma-aminobutyric acid (GABA) antibodies (B). (A, B) Upper-row boxed regions are
enlarged in lower row. Scale bar: upper row, 500 mm; lower row, 200 mm.
doi:10.1371/journal.pone.0036853.g006
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ANOVA followed by Scheffe ´’s post-hoc analysis.
RT-PCR
Total RNA was extracted from E16.5 brain using TRIzol
Reagent(Invitrogen,Carlsbad,CA).ComplementaryDNA(cDNA)
was synthesized using PrimeScript RT reagent kit with genomic
DNA Eraser (Takara, Shiga, Japan). Reverse transcription poly-
merasechainreaction(RT-PCR)wasperformedusingthefollowing
primer sets: GLAST (forward, 59-AAGCCATCATGCGATTGG-
39; reverse, 59-CTTGAAAGTGATGGGTAGGG-39), GLT1 (for-
ward, 59-CTGGTGCAAGCCTGTTTCC-39; reverse, 59-
GCCTGTTCACCCATCTTCC-39), NR1 (forward, 59-
GCCGATTTAAGGTGAACAGC-39; reverse, 59-
AATTGTGCTTCTCCATGTGC-39) and GAPDH (forward, 59-
ACTTTGTCAAGCTCATTTCC-39; reverse, 59-TGCAGC-
GAACTTTATTGATG-39). The thermal cycler conditions were
5 min at 94uC and then 35 cycles of 20 s at 94uC, 30 s at 60uC, and
45 s at 72uC, followed by 7 min at 72uC and 60 min at 4uC.
Acknowledgments
We thank S. Tonegawa for providing NR1 mutants, H. Kamiguchi for
providing the L1 antibody, and T.R. Matsugami, H. Aizawa and Y. Ito for
their technical discussions.
Author Contributions
Conceived and designed the experiments: KT. Performed the experiments:
TA YI YKT. Analyzed the data: TA YI. Wrote the paper: KT.
References
1. Fantemi SH, Folsom TD (2009) The neurodevelopmental hypothesis of
schizophrenia, revisited. Schizophr Bull 35: 528–548.
2. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, et al. (2010) Postnatal NMDA
receptor ablation in corticolimbic interneurons confers schizophrenia-like
phenotypes. Nat Neurosci 13: 76–83.
3. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of
schizophrenia. Am J Psychiatry 148: 1301–1308.
4. Krystal JH, Karper LP, Seibyl JP, FreemanGK, DelaneyR, et al. (1994)
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in
humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Arch Gen Psychiatry 51: 199–214.
5. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, et al. (1997) Ketamine-
induced exacerbation of psychotic symptoms and cognitive impairment in
neuroleptic-free schizophrenics. Neuropsychopharmacology 17: 141–150.
6. Goff DC, Coyle JT (2001) The emerging role of glutamate in the
pathophysiology and treatment of schizophrenia. Am J Psychiatry 158:
1367–1377.
7. Arguello PA, Gogos JA (2006) Modeling madness in mice: One piece at a time.
Neuron 52: 179–196.
8. Gainetdinov RR, Mohn AR, Caron MG (2001) Genetic animal models: Focus
on schizophrenia. Trends Neurosci 24: 527–533.
9. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, et al. (2007) Activation of
mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized
Phase 2 clinical trial. Nat Med 13: 1102–1107.
10. Yizhar O, Fenno LE, Prigge M, Schneider F, Davidson TJ, et al. (2011)
Neocortical excitation/inhibition balance in information processing and social
dysfunction. Nature 477: 171–178.
11. Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the
data and their interpretation. Brain 122: 593–624.
12. Arnold SE (2000) Cellular and molecular neuropathology of the parahippo-
campal region in schizophrenia. Ann N Y Acad Sci 911: 275–292.
13. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, et al. (2003)
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
Arch Gen Psychiatry 60: 443–456.
14. Volpe JJ (2001) Perinatal brain injury: from pathogenesis to neuroprotection.
Ment Retard Dev Disabil Res Rev 7: 56–64.
15. Matsugami TR, Tanemura K, Mieda M, Nakatomi R, Yamada K, et al. (2006)
Indispensability of the glutamate transporters GLAST and GLT1 to brain
development. Proc Natl Acad Sci U S A 103: 12161–12166.
16. Watanabe M, Inoue Y, Sakimura K, Mishina M (1992) Developmental changes
in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3:
1138–1140.
17. Monyer H, Seeburg PH, Wisden W (1991) Glutamate-operated channels:
developmentally early and mature forms arise by alternative splicing. Neuron 6:
799–810.
18. Bahn S, Volk B, Wisden W (1994) Kainate receptor gene expression in the
developing rat brain. J Neurosci 14: 5525–5547.
19. Shigemoto R, Nakanishi S, Mizuno N (1992) Distribution of the mRNA for
a metabotropic glutamate receptor (mGluR1) in the central nervous system: an
in situ hybridization study in adult and developing rat. J Comp Neurol 322:
121–135.
20. Li Y, Erzurumlu RS, Chen C, Jhaveri S, Tonegawa S (1994) Whisker-related
neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1
knockout mice. Cell 76: 427–437.
21. Aamodt SM, Shi J, Colonnese MT, Veras W, Constantine-Paton M (2000)
Chronic NMDA exposure accelerates development of GABAergic inhibition in
the superior colliculus. J Neurophysiol 83: 1580–1591.
22. Ben-Ari Y (2002) Excitatory actions of gaba during development: the nature of
the nurture. Nat Rev Neurosci 3: 718–739.
23. Kolevzon A, Gross R, Reichenberg A (2007) Prenatal and perinatal risk factors
for autism: a review and integration of findings. Arch Pediatr Adolesc Med 161:
326–333.
24. Schmidt-Kastner R, van Os J, Steinbusch HMW, Schmitz C (2006) Gene
regulation by hypoxia and the neurodevelopmental origin of schizophrenia.
Schizophr Res 84: 253–271.
25. Weidenhofer J, Bowden NA, Scott RJ, Tooney PA (2006) Altered gene
expression in the amygdala in schizophrenia: up-regulation of genes located in
the cytomatrix active zone. Mol Cell Neurosci 31: 243–250.
26. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al. (2008)
Rare structural variants disrupt multiple genes in neurodevelopmental pathways
in schizophrenia. Science 320: 539–543.
27. Karlsson RM, Tanaka K, Heilig M, Holmes A (2008) Loss of glial glutamate and
aspartate transporter (excitatory amino acid transporter 1) causes locomotor
hyperactivity and exaggerated responses to psychotomimetics: rescue by
haloperidol and metabotropic glutamate 2/3 agonist. Biol Psychiatry 64:
810–814.
28. Karlsson RM, Tanaka K, Saksida LM, Bussey TJ, Heilig M, et al. (2009)
Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for
phenotypes relevant to the negative and executive/cognitive symptoms of
schizophrenia. Neuropsychopharmacology 34: 1578–1589.
29. Xu S, Han JC, Morales A, Menzie CM, Williams K, et al. (2008)
Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH
for identifying genes contributing to mental retardation and autism. Cytogenet
Genome Res 122: 181–187.
30. Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum
L, Roberts W, et al. (2007) Mapping autism risk loci using genetic linkage and
chromosomal rearrangements. Nat Genet 39: 319–328.
31. Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces
opposite effects on prefrontal cortex interneurons and pyramidal neurons.
J Neurosci 27: 11496–11500.
32. Jackson ME, Homayoun H, Moghaddam B (2004) NMDA receptor hypo-
function produces concomitant firing rate potentiation and burst activity
reduction in the prefrontal cortex. Proc Natl Acad SciUSA101: 8467–8472.
33. Kargieman L, Santana N, Mengod G, Celada P, Artigas F (2007) Antipsychotic
drugs reverse the disruption in prefrontal cortex function produced by NMDA
receptor blockade with phencyclidine. Proc Natl Acad SciUSA 104:
14843–14848.
34. Watase K, Hashimoto K, Kano M, Yamada K, Watanabe M, et al. (1998)
Motor discoordination and increased susceptibility to cerebellar injury in
GLAST mutant mice. Eur J Neurosci 10: 976–988.
35. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, et al. (1997)
Epilepsy and exacerbation of brain injury in mice lacking the glutamate
transporter GLT-1. Science 276: 1699–1702.
36. Iwasato T, Erzurumlu RS, Huerta PT, Chen DF, Sasaoka T, et al. (1997)
NMDA receptor-dependent refinement of somatotopic maps. Neuron 19:
1201–1210.
NMDAR Overstimulation Impairs Brain Development
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36853